BriaCell Therapeutics Corp Warrant
BCTXW
BCTXW was delisted on the 26th of February, 2026.
3 hedge funds and large institutions have $609K invested in BriaCell Therapeutics Corp Warrant in 2024 Q1 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, reducing their positions, and 0 closing their positions.
50% more funds holding
Funds holding: 2 → 3 (+1)
0.01% more ownership
Funds ownership: 2.82% → 2.82% (+0.01%)
46% less capital invested
Capital invested by funds: $1.13M → $609K (-$516K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Osaic Holdings
Scottsdale,
Arizona
|
+$1.34K |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
AC
1
Armistice Capital
New York
| $510K | – | – | – |
|
|
RAM
2
Redmond Asset Management
Henrico,
Virginia
| $97.5K | – | – | – |
|
|
3
Osaic Holdings
Scottsdale,
Arizona
| $1.04K | +$1.34K | +800 | New |
|
BCTXW Hedge Fund Activity: Q1 2024 in Review
3 of the 6,942 institutional investors tracked by Wall St. Rank reported a position in BriaCell Therapeutics Corp Warrant (BCTXW) for Q1 2024, worth a combined $609K — down 46% from $1.13M a quarter earlier.
Buyers outnumbered sellers: 1 fund opened new BCTXW positions and 0 closed out — a net gain of 1 holder — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Osaic Holdings, opening a new position worth an estimated $1.34K.
- 3 institutional investors held BriaCell Therapeutics Corp Warrant (BCTXW) as of Q1 2024, up from 2 in Q4 2023.
- Funds reported $609K of BriaCell Therapeutics Corp Warrant stock for Q1 2024, down 46% quarter-over-quarter.
- 1 fund opened new BriaCell Therapeutics Corp Warrant positions in Q1 2024 and 0 closed out, a net change of +1 holder.
- The largest BriaCell Therapeutics Corp Warrant buyer in Q1 2024 was Osaic Holdings, an estimated $1.34K added.
Based on aggregated 13F filings for Q1 2024.